Veracyte (VCYT) News Today $26.71 +0.02 (+0.07%) As of 02:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VCYT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Veracyte (NASDAQ:VCYT) Shares Down 4.8% - Should You Sell?Veracyte (NASDAQ:VCYT) Trading Down 4.8% - Here's What HappenedJune 12 at 4:58 PM | marketbeat.comVeracyte (VCYT) Fell Despite Reporting Revenue Growth and Improved ProfitabilityJune 9, 2025 | msn.comCathie Wood's Ark Invest Loads Up On Veracyte, Offloads 3D SystemsJune 7, 2025 | benzinga.comInsider Selling: John Leite Sells Shares of Veracyte Inc (VCYT)June 6, 2025 | gurufocus.comVeracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?June 6, 2025 | msn.comCathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and GuardantJune 4, 2025 | investing.comVeracyte (VCYT) Shares Pulled Back Despite Beating ExpectationsJune 3, 2025 | msn.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by AEGON ASSET MANAGEMENT UK PlcAEGON ASSET MANAGEMENT UK Plc lowered its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 3.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 652,772 shares of the biotechnology companJune 3, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 30,059 Shares of Veracyte, Inc. (NASDAQ:VCYT)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 20.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 174,463 sharesJune 2, 2025 | marketbeat.comVeracyte (NASDAQ:VCYT) Lowered to Hold Rating by Wall Street ZenWall Street Zen downgraded shares of Veracyte from a "buy" rating to a "hold" rating in a research report on Friday.June 2, 2025 | marketbeat.comQuent Capital LLC Has $337,000 Stake in Veracyte, Inc. (NASDAQ:VCYT)Quent Capital LLC trimmed its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 49.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,354 shares of the biotechnology company's stock after selling 11,118 sharesJune 1, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Purchases New Stake in Veracyte, Inc. (NASDAQ:VCYT)Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 176,518 shares of the biotechnoloJune 1, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Given Average Rating of "Moderate Buy" by BrokeragesVeracyte, Inc. (NASDAQ:VCYT - Get Free Report) has received an average recommendation of "Moderate Buy" from the ten analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and eiMay 30, 2025 | marketbeat.comVoloridge Investment Management LLC Reduces Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)Voloridge Investment Management LLC reduced its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 65.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 85,116 shares of the biotechnology company's stock after selling 163,461May 29, 2025 | marketbeat.comVeracyte, Inc. (VCYT) Presents Breakthrough Genomic Data to Predict Cancer Therapy Response at ASCOMay 29, 2025 | insidermonkey.comVeracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer ResearchMay 28, 2025 | businesswire.comVeracyte: Upgrading To NeutralMay 26, 2025 | seekingalpha.comPalisades Investment Partners LLC Acquires New Position in Veracyte, Inc. (NASDAQ:VCYT)Palisades Investment Partners LLC bought a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 163,809 shares of the biotechnology companMay 24, 2025 | marketbeat.comMan Group plc Sells 294,029 Shares of Veracyte, Inc. (NASDAQ:VCYT)Man Group plc reduced its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 70.7% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 121,745 shares of the biotechnology company's stock after selling 294,029 shares during the perMay 23, 2025 | marketbeat.comDeutsche Bank AG Has $3.22 Million Holdings in Veracyte, Inc. (NASDAQ:VCYT)Deutsche Bank AG boosted its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 42.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 81,266 shares of the biotechnology company's stMay 23, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Acquired by Nuveen Asset Management LLCNuveen Asset Management LLC lifted its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 0.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,194,392 shares of the biotechnology company's stock after pMay 22, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Virtus Investment Advisers Inc.Virtus Investment Advisers Inc. trimmed its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 27.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 40,689 shares of the biotechnology company's stock aMay 21, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Lowers Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)D. E. Shaw & Co. Inc. reduced its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 9.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 86,182 shares of the biotechnology company's stock after selling 8,848 shares duringMay 21, 2025 | marketbeat.comVeracyte to Participate in Upcoming Investor ConferencesMay 20, 2025 | businesswire.comPoint72 Asset Management L.P. Buys Shares of 523,162 Veracyte, Inc. (NASDAQ:VCYT)Point72 Asset Management L.P. bought a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 523,162 shares of the bioteMay 20, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $7.61 Million Position in Veracyte, Inc. (NASDAQ:VCYT)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lowered its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 8.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 192,151 shares of tMay 20, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Bank of America Corp DEBank of America Corp DE lessened its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 53.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 742,709 shares of the biotechnology company's stock aftMay 20, 2025 | marketbeat.comBNP Paribas Financial Markets Sells 55,684 Shares of Veracyte, Inc. (NASDAQ:VCYT)BNP Paribas Financial Markets lowered its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 56.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 42,738 shares of the biotechnology company's stock after selling 55,684 shares dMay 20, 2025 | marketbeat.comLazard Asset Management LLC Boosts Holdings in Veracyte, Inc. (NASDAQ:VCYT)Lazard Asset Management LLC lifted its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 36.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 97,809 shares of the biotechnology company's stock after purchasMay 19, 2025 | marketbeat.comResearch Analysts Set Expectations for Veracyte Q2 EarningsVeracyte, Inc. (NASDAQ:VCYT - Free Report) - Stock analysts at William Blair raised their Q2 2025 EPS estimates for shares of Veracyte in a report issued on Tuesday, May 13th. William Blair analyst A. Brackmann now forecasts that the biotechnology company will earn $0.19 per share for the quarterMay 18, 2025 | marketbeat.comParkman Healthcare Partners LLC Reduces Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)Parkman Healthcare Partners LLC cut its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 22.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 100,301 shares of the biotechnology company's stock after sellingMay 16, 2025 | marketbeat.comGranahan Investment Management LLC Has $1.96 Million Holdings in Veracyte, Inc. (NASDAQ:VCYT)Granahan Investment Management LLC reduced its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 84.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 49,515 shares of the biotechnology company'May 13, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Acquired by Fred Alger Management LLCFred Alger Management LLC boosted its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 254.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,892 shares of the biotechnology company's stock after buyingMay 13, 2025 | marketbeat.comAxa S.A. Trims Holdings in Veracyte, Inc. (NASDAQ:VCYT)Axa S.A. reduced its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 49.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 63,103 shares of the biotechnology company's stock after selMay 11, 2025 | marketbeat.comNorthern Trust Corp Has $42.34 Million Stock Position in Veracyte, Inc. (NASDAQ:VCYT)Northern Trust Corp boosted its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 12.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,069,187 shares of the biotechnology company's stock after purchasing an addMay 11, 2025 | marketbeat.comBreaking Down Veracyte: 7 Analysts Share Their ViewsMay 10, 2025 | nasdaq.comVeracyte, Inc. Just Recorded A 260% EPS Beat: Here's What Analysts Are Forecasting NextMay 10, 2025 | finance.yahoo.comVeracyte (NASDAQ:VCYT) Price Target Cut to $41.00 by Analysts at Needham & Company LLCNeedham & Company LLC lowered their target price on Veracyte from $51.00 to $41.00 and set a "buy" rating for the company in a report on Thursday.May 10, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Bought by Driehaus Capital Management LLCDriehaus Capital Management LLC lifted its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 226.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,183,766 shares of thMay 10, 2025 | marketbeat.comCaption Management LLC Invests $376,000 in Veracyte, Inc. (NASDAQ:VCYT)Caption Management LLC purchased a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,500 shares of the biotechnology coMay 10, 2025 | marketbeat.comTudor Investment Corp ET AL Sells 20,531 Shares of Veracyte, Inc. (NASDAQ:VCYT)Tudor Investment Corp ET AL lessened its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 50.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,342 shares of the biotechnology company's stockMay 10, 2025 | marketbeat.comBridgeway Capital Management LLC Decreases Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)Bridgeway Capital Management LLC lowered its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 15.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 169,400 shares of the biotechnology company's stock afterMay 9, 2025 | marketbeat.comAQR Capital Management LLC Grows Holdings in Veracyte, Inc. (NASDAQ:VCYT)AQR Capital Management LLC increased its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 21.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 230,299 shares of the biotechnology company'May 9, 2025 | marketbeat.com4VCYT : Breaking Down Veracyte: 7 Analysts Share Their ViewsMay 8, 2025 | benzinga.comCasdin Capital LLC Decreases Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)Casdin Capital LLC lowered its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 58.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 276,308 shares of the biotechnology company's stock after selling 390,000 shares duMay 8, 2025 | marketbeat.comVeracyte Inc (VCYT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ExpansionsMay 8, 2025 | finance.yahoo.comBosun Asset Management LLC Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT)Bosun Asset Management LLC bought a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 15,261 shares of the biotechnology company'May 8, 2025 | marketbeat.comBayesian Capital Management LP Takes Position in Veracyte, Inc. (NASDAQ:VCYT)Bayesian Capital Management LP bought a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 17,500 shares of the biotechnology company's stock, valued at approximately $693,000.May 8, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Has $1.85 Million Stake in Veracyte, Inc. (NASDAQ:VCYT)Schonfeld Strategic Advisors LLC raised its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 200.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,820 shares ofMay 8, 2025 | marketbeat.comVeracyte, Inc. (VCYT) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.com Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address VCYT Media Mentions By Week VCYT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCYT News Sentiment▼1.010.88▲Average Medical News Sentiment VCYT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCYT Articles This Week▼67▲VCYT Articles Average Week Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Guardant Health News Today Option Care Health News Today RadNet News Today BrightSpring Health Services News Today Sotera Health News Today Surgery Partners News Today Privia Health Group News Today Concentra Group Holdings Parent News Today LifeStance Health Group News Today Addus HomeCare News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCYT) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VCYT Stock Free VCYT Stock Alerts